Lonza to Co-Develop Novartis Biologics Pipeline

Lonza says it has entered into a long-term partnership with Novartis to jointly develop and manufacture Novartis’s biologics pipeline. Under the deal, Lonza will provide services from its R&D center at Slough, U.K. using its GS Gene Expression System as well as its large-scale manufacturing capacity from operations in Singapore, Spain, and the U.S. Kutzer: A change in approach. Novartis says it aims to further grow its biologics pipeline, which has risen during the last few years to about one-quarter of its total R&D portfolio. Novartis says its...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers